Melanotan (I)
Pharmacy
|
-
Currently 0.00/5
- 1
- 2
- 3
- 4
- 5
Rating: 0.0 out of 0 votes
Comments (0)
|
You need to have the
Flash Player installed and
a browser with JavaScript support.
Description
Melanotan (I) "afamelanotide" phase III trial results for the skin disease EPP are reported on by 7 Today Tonight's Jackie Quist. The Australian company Clinuvel reports on successful results of phase III human clinical trials for sufferers of Erythropoietic protoporphyria (EPP). Also covered is news about an ongoing human trial conducted by Dr. George Varigos for human organ transplant patients to help prevent skin cancers in this population of individuals. Clinuvel's CEO Dr. Philippe Wolgen explains how the peptide works.
|
Tags
|
Sign in or sign up to post comments.